Education
About Us
Working with TipRanks
Follow Us
Delivra Health Brands (TSE:DHB)
:DHB
DHB Stock Chart & Stats
C$0.18
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.18
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.14 - C$0.37
Previous CloseN/A
Volume20.60K
Average Volume (3M)26.13K
Market Cap
C$5.94M
Enterprise ValueC$4.97M
Total Cash (Recent Filing)C$3.23M
Total Debt (Recent Filing)C$2.26M
Price to Earnings (P/E)―
Beta1.53
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding31,261,782
10 Day Avg. Volume58,945
30 Day Avg. Volume26,134
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.30
Price to Sales (P/S)0.41
P/FCF Ratio-7.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$14.97M
Bulls Say, Bears Say
Bulls Say
Sustained High Gross MarginConsistently ~50% gross margins provide structural profit leverage for Delivra’s topical and OTC product mix. High unit economics give room to invest in marketing and distribution while protecting margins as revenue scales, supporting a durable path toward operating profitability.
Multi-year Revenue Expansion And Operational ImprovementSeveral years of revenue expansion and operational improvement indicate a working commercial model and product-market fit. Sustained growth from 2021–2025 suggests the company can scale distribution and reduce per-unit costs, improving durability of future margins if trends continue.
Manageable Leverage And Positive Equity CushionModerate debt levels and positive equity provide balance-sheet flexibility for a small issuer, limiting refinancing pressure. Manageable leverage supports continued investment in retail and e-commerce channels and reduces bankruptcy risk compared with highly leveraged peers over the medium term.
Bears Say
Inconsistent Cash GenerationVolatile cash flow with a recent material annual cash burn undermines financial flexibility. Inconsistent free cash flow limits the company’s ability to self-fund marketing, inventory and working capital needs, increasing reliance on external capital and diluting long-term shareholder value risk.
Ongoing Net LossesPersistent negative net margins and slightly negative EBIT show the turnaround is incomplete. Without durable operating profitability, losses can erode equity over time and constrain reinvestment capacity, making sustainable returns dependent on sustained revenue scale or cost reductions.
Slowing Recent Revenue MomentumA TTM revenue decline after prior multi-year expansion signals vulnerability in demand or distribution execution. Slowing top-line momentum impairs operating leverage and delays margin recovery, making achievement of consistent positive cash flow and profits less certain over the next several quarters.
Delivra Health Brands News
DHB FAQ
What was Delivra Health Brands’s price range in the past 12 months?
Delivra Health Brands lowest stock price was C$0.14 and its highest was C$0.37 in the past 12 months.
What is Delivra Health Brands’s market cap?
Delivra Health Brands’s market cap is C$5.94M.
When is Delivra Health Brands’s upcoming earnings report date?
Delivra Health Brands’s upcoming earnings report date is May 27, 2026 which is in 71 days.
How were Delivra Health Brands’s earnings last quarter?
Delivra Health Brands released its earnings results on Feb 27, 2026. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Delivra Health Brands overvalued?
According to Wall Street analysts Delivra Health Brands’s price is currently Overvalued.
Does Delivra Health Brands pay dividends?
Delivra Health Brands does not currently pay dividends.
What is Delivra Health Brands’s EPS estimate?
Delivra Health Brands’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delivra Health Brands have?
Delivra Health Brands has 31,261,782 shares outstanding.
What happened to Delivra Health Brands’s price movement after its last earnings report?
Delivra Health Brands reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Delivra Health Brands?
Currently, no hedge funds are holding shares in TSE:DHB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Delivra Health Brands
Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. The company is involved in selling of cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It offers its products under LivRelief, Dream Water, and LivRelief infused brand names. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.
Technical Analysis
Options Prices
Currently, No data available
---